Marta Lasa^1*, Mario Nuvolone, MD, PhD^2,3*, Ioannis V Kostopoulos, PhD^4*, Tomas Jelinek, MD, PhD^5*, Marco Basset, MD, PhD^3*, Paolo Milani, MD, PhD^6,7, Margherita Massa, PhD^8*, Foteini Theodorakakou, MD^9*, Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath^10,11,12, Anastasiia Zherniakova, MD, PhD^13*, Rafael Ríos, MD, PhD^14*, Irene Romera^15*, Maria Teresa Cedena Romero, MD, PhD^16*, Noemi Puig, PhD¹⁷, Ramon Lecumberri Villamediana, MD, PhD^18*, Jesús F. San-Miguel, MD, PhD¹⁹, Roman Hajek, MD, PhD²⁰, Giampaolo Merlini, MD, PhD^3,21*, Efstathios Kastritis, MD, PhD^9*, Bruno Paiva, PhD^22* and Giovanni O. Palladini, MD, PhD²³

¹Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369, Pamplona, Spain
²Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia, Pavia, Italy, Pavia, Italy
³Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁴Department of Biology, School of Science, National and Kapodistrian University of Athens (NKUA), Athens, Greece
⁵Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic
⁶Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo," and Department of Molecular Medicine, University of Pavia, Pavia, Italy
⁷Foundation IRCCS Policlinico San Matteo, Pavia, Italy
⁸IRCCS Policlinico S. Matteo Foundation, Pavia, ITA
⁹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹⁰Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹¹Royal Free London Hospital, National Amyloid Centre, London, United Kingdom
¹²University College London Hospital, London, United Kingdom
¹³Russian Research Institute of Hematology and Transfusiology, Saint-Petersburg, Russian Federation
¹⁴Hospital Universitario Virgen De Las Nieves, Granada, ESP
¹⁵Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, AL, Spain
¹⁶Instituto de Investigación IMAS12, Madrid, Spain
¹⁷Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
¹⁸Hematology and Cell Therapy Department. Clinica Universidad de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
¹⁹Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBER-ONC CB16/12/00369, Pamplona, Spain, Pamplona, Spain
²⁰University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic
²¹University of Pavia, Pavia, ITA
²²Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
²³Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo," and Department of Molecular Medicine, University of Pavia, Pavia, PV, Italy

Jahanzaib Khwaja^1,2, Sriram Ravichandran^1*, Joshua Bomsztyk^2*, Oliver Charles Cohen^2*, Darren Foard^2*, Ana Martinez-Naharro^2*, Lucia Venneri^2*, Marianna Fontana^2*, Carol Whelan^2*, Philip N Hawkins^2*, Julian Gillmore^2*, Helen J Lachmann^2*, Shameem Mahmood^2*, Amy A Kirkwood, MSc^3* and Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath^1,2

¹University College London Hospital, London, United Kingdom
²Royal Free London Hospital, National Amyloid Centre, London, United Kingdom
³Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom

Efstathios Kastritis, MD^1*, Giovanni O. Palladini, MD, PhD², Monique C. Minnema³, Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath⁴, Arnaud Jaccard, MD, PhD^5*, Hans C. Lee, MD⁶, Vaishali Sanchorawala⁷, Peter Mollee, FRACP, MBBS, MSc, FRCPA⁸, Jin Lu^9*, Stefan Schönland^10*, Moshe E Gatt, MD¹¹, Kenshi Suzuki, MD, PhD¹², Kihyun Kim, MD^13*, M. Teresa Cibeira, MD, PhD^14*, Manisha Bhutani, MD¹⁵, Meral Beksac^16*, Edward Libby, MD¹⁷, Jason Valent, MD¹⁸, Vania Hungria, MD, PhD¹⁹, Michael Rosenzweig, MD²⁰, Naresh Bumma, MD²¹, Antoine Huart, MD^22*, NamPhuong Tran^23*, Jianping Wang^24*, Yuping Chen^25*, Sandra Y. Vasey^26*, Jordan M. Schecter²⁴, Jessica Vermeulen, MD, PhD²⁷, Raymond L. Comenzo^28* and Giampaolo Merlini, MD, PhD^2*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Voula,Athens, AL, Greece
²Department of Molecular Medicine, University of Pavia, Pavia, Italy
³Department of Hematology, University Medical Center Utrecht, University Utrecht, Utrecht, Netherlands
⁴University College London, London, United Kingdom
⁵Reference Center for AL Amyloidosis, Limoges, France
⁶Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁸Department of Haematology, Princess Alexandra Hospital and University of Queensland Medical School, Brisbane, Australia
⁹Peking University Institute of Hematology, Peking University Peoples’ Hospital, Beijing, China
¹⁰Universitaetsklinikum Heidelberg Medizinische Klinik V, Heidelberg, Germany
¹¹Hadassah Medical Center, Jerusalem, Israel
¹²Japanese Red Cross Central Medical Center, Shibuya, Tokyo, Japan
¹³Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
¹⁴Hospital Clinic of Barcelona, Barcelona, Spain
¹⁵Department of Hematologic Oncology and Blood Disorders, Atrium Health/Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC
¹⁶Ankara Liv Hospital, Istinye University, Ankara, Turkey
¹⁷Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
¹⁸Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
¹⁹Clinica São Germano, São Paulo, Brazil
²⁰Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
²¹Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
²²CHU Rangueil, Toulouse, France
²³Janssen Research & Development, LLC, Los Angeles, CA
²⁴Janssen Research & Development, LLC, Raritan, NJ
²⁵Janssen Research & Development, LLC, Shanghai, China
²⁶Janssen Research & Development, LLC, Spring House, PA
²⁷Janssen Research & Development, LLC, Leiden, Netherlands
²⁸John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA

Peter Mollee, FRACP, MBBS, MSc, FRCPA¹, Antoine Huart, MD^2*, Olga Mortona, MBBS BA BCh BAO FRACP FRCPA^3*, Kentin Queru, MD^4*, Cecile Leyronnas, MD^5*, Harel Stephanie, MD^6*, Hasib Sidiqi, MBBS, FRACP, FRCPA^7*, Estelle Desport, MD^8*, Laure Vincent, MD^9*, Margaret Macro, MD^10*, Salomon Manier, MD, PhD¹¹, Caroline Jacquet, MD^12*, Pierre Morel, MD, PhD^13*, Noemi Horvath¹⁴, Sebastien Bender, PhD^15,16*, Guillaume Olombel, MD^15*, Virginie Pascal, MD, PhD^16*, Jill Corre, PharmD, PhD^17*, Frank Bridoux, MD, PhD^8*, Arnaud Jaccard, MD, PhD^4* and Murielle Roussel, MD^4*

¹Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
²Department of Nephrology and Organs Transplantation, CHU de Toulouse Rangueil, Toulouse, France
³Eastern Haematology Oncology Group, Austin Hospital, Monash Health and Eastern Health, Box Hill VIC 3128, Australia
⁴Hématologie Clinique, CHU de Limoges, Limoges, France
⁵Hématologie, CHU de Grenoble, Grenoble, FRA
⁶Department of Immuno-hematology,, Saint Louis Hospital, APHP, Paris, France
⁷Fiona Stanley Hospital, Southbank, Australia
⁸Néphrologie, CHU de Poitiers, Poitiers, France
⁹Department of Clinical Hematology, Hôpital St Eloi, CHU de Montpellier, Montpellier, France
¹⁰Hopital Cote De Nacre, Caen, France
¹¹Centre Hospitalier Universitaire - Hôpital Huriez, Lille, France
¹²CHU de Nancy, Vandoeuvre Les Nancy, FRA
¹³Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Salouel, France
¹⁴Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, Australia
¹⁵Immunologie, CHU de Limoges, Limoges, France
¹⁶CNRS UMR 7276, INSERM UMR 1262, Université de Limoges, Limoges, France
¹⁷Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

Kaini Shen, MD^1*, Ai Guan, MD^2*, Yu Wu, MD³, Chunyan Sun^4*, Liye Zhong, MD, PhD^5*, Jun Luo, MD^6* and Jian Li, MD⁷

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, CHN
²Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
³Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
⁴Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Guangdong Provinal People's Hospital, Guangzhou, China
⁶Department of Haematology, THE FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY, Nanning, China
⁷Department of Hematology, Peking Union Medical College Hospital, Beijing, China

Eyal Lebel^1*, Nathalie Asherie^1,2*, Miri Assayag^1,2*, Shlomo Elias, MD, PhD^1,2, Sigal Grisariu, MD^1,2*, Batia Avni, MD^1,2*, Shlomit Kfir-Erenfeld^1,2*, Tali Dubnikov-Sharon^1*, Rivka Alexander-Shani^1*, Nomi Bessig^1*, Alaa Shehadeh^1*, Aseel Ishtay^1*, Shelly Pimienta^1*, Vladimir Vaistein^2,3*, Eran Zimran^1,4*, Marjorie Pick^3*, Yael C. Cohen^5,6, Irit Avivi Mazza^5,6*, Cyrille Cohen^7*, Polina Stepensky^1,8* and Moshe E Gatt, MD^2,3

¹Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Jerusalem, Israel
²Faculty of Medicine, The Hebrew University, Jerusalem, Israel
³Department of Hematology, Hadassah Medical Center, Jerusalem, Israel
⁴Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
⁵Department of Hematology, Tel Aviv Medical Center, Tel Aviv, Israel
⁶Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁷Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel
⁸Hadassah University Hospital, Jerusalem, Israel